Cognoa CMO, Sharief Taraman, MD, DABPN, DABPM, FAAP, authored a MedCity News Influencer article about the potential of digital therapeutics and ai to empower pediatricians and make early intervention possible for more children. Our mental and behavioral health is largely determined by how the brain develops during the first few years of life when the brain is most actively developing.…
Palo Alto, Calif., December 18, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Science Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity to receive treatments earlier when they can have the greatest impact. Currently, diagnosis and treatment of behavioral…
Currently, most pediatricians choose to refer children to a specialist to be diagnosed and treated for behavioral conditions such as autism — often with waitlists of a year to three years. Nationwide, we continue to face an enormous and growing shortage of specialists, so the heartbreaking reality for most children and families is delayed diagnosis and late access to treatments.…
Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children Palo Alto, Calif., December 5, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, announced today that it has been selected as a finalist in Questex’s Fierce Innovation Awards – LifeSciences Edition 2019, a…
Palo Alto, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences: BTIG Digital Health 2019: Industry Innovators on What’s Next. Panel entitled, “Developing Commercial Models for Prescription Digital Therapeutics” on Wednesday, November 20 at 1:35 p.m. Eastern Time in New…
By Brent Vaughan, CEO and Co-Founder, Cognoa. We are experiencing a mental health crisis:one person in every four in the world will develop one or more behavioral conditions during their lifetime. Today in the U.S., one in five children have a diagnosable behavioral health disorder and only 21% of those children receive needed treatment. Read full article here.
Palo Alto, Calif. and Orlando, Oct. 28, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit. Andy Molnar, Vice President of Commercialization at Cognoa will also speak at HLTH about reimbursement strategies…
